Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      The Link Between Gastric Ulcers and Stomach Cancer

      June 16, 2014
      Commentary
      Article

      Recent studies have established the link between a gastric ulcer and stomach cancer. A gastric or peptic ulcer is a sore that can develop on the walls of the stomach when the protective lining in our stomach stops working.

      Recent studies have established the link between a gastric ulcer and stomach cancer. A gastric or peptic ulcer is a sore that can develop on the walls of the stomach when the protective lining in our stomach stops working. The digestive system gets eroded by acidic digestive juices and hence a sour stomach may be an early sign of this disease.

      How Ulcer Leads To Cancer — Gastric ulcers are mainly caused due to the presence of the helicobacter pylori bacteria. The infection caused by H pylori is also linked to carcinoma or cancer. As a gastric ulcer is an open sore, bacteria can infect it easily. It causes mutations in the DNA and damages the cells of the stomach lining. Long-standing inflammation can lead to chronic inflammation of the stomach and even stomach cancer. The damaged gastric tissue is replaced by intestinal or fibrous tissue naturally. This transformation is one of the first symptoms of stomach cancer as it increases the chances of its occurrence.

      Increased Risk — The chances of an ulcer turning to stomach cancer is heightened by certain factors. Individuals with gastric ulcer should be aware that drinking, smoking, or chewing tobacco can accelerate the chances of the ulcer turning into stomach cancer. They increase the production of stomach acids.

      Aspirin and other anti-inflammatory drugs reduce the stomach's ability to produce a protective mucus. They also accelerate the production of acids in the stomach. Such medicines reduce the flow of blood to the stomach, thus undermining the body's ability to repair cells. All of these factors increase the chances of developing cancer.

      For patients with stomachache, nausea, or vomiting, it's always better to get checked by a doctor as soon as possible. All these may possibly be the symptoms of stomach cancer. There is medication available for curing gastric ulcer before it reaches the cancerous stage. Medications reduce the acid levels in the stomach and prevent the chances of its recurrence.

      Complications — Gastric ulcer is definitely curable; even stomach cancer in the first stages can be curable. But why allow a stomach ulcer to turn into cancer due to sheer negligence? The walls of the stomach get perforated and lead to cancer and internal bleeding. So be wary of such complications and consult a doctor if you have any symptoms of a stomach ulcer.

      More: Gastrointestinal Cancer

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      a man wearing a suit and tie in front of a green screen with the ONN logo
      Karyn Goodman
      Expert in oncology
      Expert in oncology
      Experts in oncology
      Expert in oncology
      Expert in oncology
      Expert in oncology
      Related Content

      Graphic of a person's gastrointestinal tract.

      Retifanlimab Lengthens Survival for Patients With Anal Cancer

      Sabrina Serani
      July 24th 2025
      Article

      The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell carcinoma of the anal canal.


      The Vitals

      ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

      Lindsay Fischer
      October 31st 2023
      Podcast

      Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.


      Graphic of a person's esophagus and stomach

      Zanidatamab/Chemo Yields Durable Response in HER2+ Gastroesophageal Cancer

      Russ Conroy
      July 10th 2025
      Article

      Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.


      The Vitals

      Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

      Lindsay Fischer
      March 1st 2023
      Podcast

      In this episode of "The Vitals," Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC, underscores potentially practice-changing data which were presented during the 2023 GI Cancers Symposium.


      Anatomical image of the gastroesophageal tract in the human body

      Durvalumab/FLOT Potential SOC in Resectable Gastric/GEJ Adenocarcinoma

      Chris Ryan
      June 2nd 2025
      Article

      Adding durvalumab to perioperative FLOT upped event-free survival in patients with gastric or gastroesophageal adenocarcinoma eligible for resection.


      Anatomical image of a person's gastrointestinal tract

      T-DXd Earns Second-Line SOC for HER2+ Gastric/GEJ Cancer

      Tim Cortese
      May 31st 2025
      Article

      T-DXd led to improvements in OS, PFS, ORR, and DOR compared with ramucirumab/paclitaxel in the second line for HER2-positive gastric and GEJ cancer.

      Related Content

      Graphic of a person's gastrointestinal tract.

      Retifanlimab Lengthens Survival for Patients With Anal Cancer

      Sabrina Serani
      July 24th 2025
      Article

      The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell carcinoma of the anal canal.


      The Vitals

      ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

      Lindsay Fischer
      October 31st 2023
      Podcast

      Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.


      Graphic of a person's esophagus and stomach

      Zanidatamab/Chemo Yields Durable Response in HER2+ Gastroesophageal Cancer

      Russ Conroy
      July 10th 2025
      Article

      Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.


      The Vitals

      Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

      Lindsay Fischer
      March 1st 2023
      Podcast

      In this episode of "The Vitals," Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC, underscores potentially practice-changing data which were presented during the 2023 GI Cancers Symposium.


      Anatomical image of the gastroesophageal tract in the human body

      Durvalumab/FLOT Potential SOC in Resectable Gastric/GEJ Adenocarcinoma

      Chris Ryan
      June 2nd 2025
      Article

      Adding durvalumab to perioperative FLOT upped event-free survival in patients with gastric or gastroesophageal adenocarcinoma eligible for resection.


      Anatomical image of a person's gastrointestinal tract

      T-DXd Earns Second-Line SOC for HER2+ Gastric/GEJ Cancer

      Tim Cortese
      May 31st 2025
      Article

      T-DXd led to improvements in OS, PFS, ORR, and DOR compared with ramucirumab/paclitaxel in the second line for HER2-positive gastric and GEJ cancer.

      Latest Conference Coverage

      Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL

      Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts

      Proactive Rash Management Vital for PI3K, AKT Inhibition in Breast Cancer

      Understanding How On-Target and Off-Target ADC Toxicities Work

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.